Bryan Kobel
Chief Executive Officer bij TC BIOPHARM (HOLDINGS) PLC
Vermogen: 773 $ op 30-11-2023
Profiel
Presently, Bryan Kobel is Chief Executive Officer & Director at TC Biopharm (Holdings) Plc.
He is also CEO-Biopharm North America at TCB Newco Ltd.
In the past he occupied the position of Head-Capital Markets at R.F.
Lafferty & Co., Inc., Head-Healthcare Investment Banking at HUTN, Inc., Managing Director at The Alberleen Group LLC and Managing Director at Laidlaw & Co. (UK) Ltd.
Bryan Kobel received an undergraduate degree from Franklin & Marshall College.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
06-02-2024 | 2 101 ( 0.22% ) | 773 $ | 30-11-2023 |
Actieve functies van Bryan Kobel
Bedrijven | Functie | Begin |
---|---|---|
TC BIOPHARM (HOLDINGS) PLC | Chief Executive Officer | 01-06-2021 |
TCB Newco Ltd.
TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Corporate Officer/Principal | - |
TC BioPharm (North America), Inc. | Chief Executive Officer | 01-06-2021 |
Eerdere bekende functies van Bryan Kobel
Bedrijven | Functie | Einde |
---|---|---|
The Alberleen Group LLC
The Alberleen Group LLC Investment Banks/BrokersFinance The Alberleen Group LLC provides investment banking services. The firm offers mergers, acquisitions advice, capital raising services, investment opportunities and merchant banking services. It serves to the energy, financials, healthcare, real estate industries. The company was founded by Jolyne Caruso in July 2010 and is headquartered in New York, NY. | Corporate Officer/Principal | 01-10-2020 |
R.F. Lafferty & Co., Inc.
R.F. Lafferty & Co., Inc. Investment Banks/BrokersFinance Founded in 1946, R.F. Lafferty & Co., Inc. is a brokerage firm and registered investment advisor located in New York City. The firm's research focuses on small- and mid-cap companies. | Corporate Officer/Principal | 01-06-2018 |
Laidlaw & Co. (UK) Ltd.
Laidlaw & Co. (UK) Ltd. Investment Banks/BrokersFinance Part of Laidlaw Holdings Ltd., Laidlaw & Co. (UK) Ltd. is a British company that provides investment advice. The private company is based in London, UK. The company was founded in 1842. Matthew D. Eitner has been the CEO of the company since 2010. | Corporate Officer/Principal | 01-04-2017 |
HUTN, INC. | Corporate Officer/Principal | - |
Opleiding van Bryan Kobel
Franklin & Marshall College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
HUTN, INC. | Finance |
TC BIOPHARM (HOLDINGS) PLC | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
R.F. Lafferty & Co., Inc.
R.F. Lafferty & Co., Inc. Investment Banks/BrokersFinance Founded in 1946, R.F. Lafferty & Co., Inc. is a brokerage firm and registered investment advisor located in New York City. The firm's research focuses on small- and mid-cap companies. | Finance |
Laidlaw & Co. (UK) Ltd.
Laidlaw & Co. (UK) Ltd. Investment Banks/BrokersFinance Part of Laidlaw Holdings Ltd., Laidlaw & Co. (UK) Ltd. is a British company that provides investment advice. The private company is based in London, UK. The company was founded in 1842. Matthew D. Eitner has been the CEO of the company since 2010. | Finance |
The Alberleen Group LLC
The Alberleen Group LLC Investment Banks/BrokersFinance The Alberleen Group LLC provides investment banking services. The firm offers mergers, acquisitions advice, capital raising services, investment opportunities and merchant banking services. It serves to the energy, financials, healthcare, real estate industries. The company was founded by Jolyne Caruso in July 2010 and is headquartered in New York, NY. | Finance |
TCB Newco Ltd.
TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Health Technology |
TC BioPharm (North America), Inc. |